ClearAE continuously analyzes adverse event data to identify safety data quality issues, strengthen regulatory readiness, and support safer and more reliable clinical trials, including oncology studies.
Clinical trial safety management has become increasingly complex. Manual review of adverse event data is time-consuming, error-prone, and often reactive rather than proactive.
Teams struggle with fragmented data sources, inconsistent data quality, and pressure to maintain regulatory compliance while keeping trials on track.
The result: delayed risk identification, compliance gaps, and resources stretched thin across manual safety processes.
Data quality issues across trials slow review and increase compliance risk.
Safety teams spend countless hours on repetitive data review instead of strategic analysis.
Late identification of safety signals risks regulatory scrutiny and timeline delays.
ClearAE is an AI-powered safety intelligence platform that integrates with existing clinical workflows, reduces manual safety review burden, detects inconsistencies, and supports early risk identification—delivering continuous safety intelligence exactly when you need it.
AI-powered continuous analysis of adverse event data with real-time intelligence and pattern detection for proactive safety oversight.
Automatically identifies data inconsistencies, quality issues, and anomalies that could impact regulatory readiness and trial safety.
Strengthens regulatory readiness through comprehensive safety documentation, audit trails, and compliance-focused intelligence.
ClearAE integrates seamlessly with existing clinical workflows and safety systems to continuously ingest adverse event data from multiple sources.
Advanced AI models continuously analyze adverse event data to detect patterns, inconsistencies, quality issues, and emerging safety signals.
Safety teams receive actionable intelligence, prioritized alerts, and quality recommendations to support informed decision-making and regulatory compliance.
Accelerate trial timelines and reduce safety review overhead with continuous, automated intelligence.
Support multiple sponsors with standardized, scalable safety intelligence across diverse trial portfolios.
Shift focus from reactive data entry to proactive safety oversight and strategic analysis.
Catch safety signals early with continuous monitoring and intelligent risk detection from day one.
Navigate complex safety profiles with AI-powered intelligence designed for high-risk therapeutic areas.
Early detection means better patient safety and trial integrity.
Meet compliance requirements with continuous documentation and audit trails.
Automate routine tasks so teams can focus on strategic analysis.
AI-powered analysis flags problems before they become compliance risks.
Continuous monitoring enables proactive, data-driven decision-making.
To improve clinical trial safety and regulatory readiness through continuous safety intelligence—empowering teams to make better decisions faster and protecting patients.
Solaris Innovations Canada Inc. is dedicated to advancing clinical trial safety through AI-powered intelligence. We believe that better data analysis leads to better decisions—and better decisions lead to safer trials.
ClearAE represents our commitment to reducing the burden on safety and pharmacovigilance teams while strengthening regulatory confidence and protecting patients across clinical research.
We work closely with biotechnology companies, CROs, and clinical teams to integrate safety intelligence into workflows that matter—supporting the future of clinical trial excellence.
Let's discuss how continuous safety intelligence can transform your trial operations.
Schedule a conversation